Bright Photomedicine

Bright Photomedicine

Private
BrazilHealthcare & Life Scienceshttps://www.brightmed.com.br

Last Round

Grant

Jul 1, 2023

Total Funding Raised

$810,000

Company Overview

Bright Photomedicine is a Brazilian medical technology company founded in 2014 that develops and commercializes a platform for pain and inflammation treatment based on photobiomodulation. The company's main offering, known as "fotocêuticos" (photopharmaceuticals), is a light-emitting device, sometimes referred to as Light-Aid, which provides a personalized pattern of light emission to alleviate musculoskeletal pain. The therapy is customized for each patient based on factors like skin color, fat percentage, and clinical condition, with doses controlled via a smartphone application. The system is designed for use under medical prescription and is registered with Brazil's regulatory agency, Anvisa. The company has raised venture capital from investors including Squared Ventures and Parallax Ventures.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Biotechnology, Precision Medicine, Clinical Trials

Business Model

B2B

Customer Profile

Hardware Sales, Usage-Based SaaS, Services & Consulting

AI Layer

Non-AI

Keywords

photobiomodulationPBMlight therapyred light therapymusculoskeletal pain treatmentlow-level laser therapynon-pharmacological pain reliefwearable medical deviceprescribed light therapycustomized light dosagemedical devicenear-infrared light therapyosteoarthritis treatmentlight-emitting bandageconnected medical deviceclinical trials

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Bright Photomedicine Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Bright Photomedicine Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
GrantJul 1, 2023
GrantApr 1, 2021
CrowdfundingFeb 27, 2019
GrantMay 1, 2017

Bright Photomedicine Investors

Notable investors and investment history

InvestorRounds
SebraeGrant

Bright Photomedicine Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Bright Photomedicine Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Bright Photomedicine's valuation, stock price, and market status.

Firmographic Details

HeadquartersBrazil
Employee Range6
Year Founded2014
Last FundingJul 1, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.